A diagnostic and prognostic value of blood-based circulating long non-coding RNAs in thyroid, pancreatic and ovarian cancer

Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection

“…In addition to breast and lung cancer, ovarian cancer is also known as the "silent killer" because of its poor diagnosis at early stages. It is one of the most highly fatal gynecological malignancies [125] . Recent studies identified the significant contribution of flavonoids in regulating the expression of underpinnings molecules, such as dysregulated miRNA, which is responsible for the alteration of the cascade of downstream molecules.…”